|
시장보고서
상품코드
1478651
장골 스텐트 시장, 점유율, 시장 규모, 동향, 산업 분석 보고서 : 유형별, 동맥 병변별, 최종 용도별, 지역별, 부문별 예측(2024-2032년)Iliac Stent Market Share, Size, Trends, Industry Analysis Report, By Type (Self-expandable Stents, Balloon-expandable Stents, Others); By Artery lesions; By End Use, By Region, And Segment Forecasts, 2024 - 2032 |
||||||
Polaris Market Research의 최신 조사에 따르면 장골 스텐트 세계 시장 규모는 2032년까지 17억854만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
장골 동맥 병변 및 동맥류 치료를 위한 장골 스텐트 수술에는 여러 가지 스텐트가 사용됩니다. 연구에 따르면 장골 동맥 병변 관리와 관련하여 EPIC 스텐트와 같은 스텐트가 다른 스텐트보다 더 나은 임상 결과를 보여줍니다. 자기 확장형 EPIC 스텐트는 유연성, 치유력 향상 및 신생 내막 과형성 감소로 인해 장골 동맥 시술에 대한 유망한 선택입니다.
미국심장협회(AHA)가 발표한 자료에 따르면, 미국에서는 약 850만 명의 성인이 말초동맥질환(PAD)을 앓고 있으며, PAD는 장골동맥을 막는 질환으로 원활한 심장기능을 위해 장골 스텐트 삽입을 필요로 합니다.
또한, 장골동맥류 치료에는 개복 수술을 통한 이식편 삽입 대신 경피적 스텐트 이식술이 사용되고 있습니다. 장골 동맥류 치료에서 스텐트 그라프트를 이식하는 이 최소 침습적 치료법은 기존의 외과적 재건 수술보다 덜 침습적인 방법을 제공합니다.
DISCOVER 연구는 장골 동맥의 경우, PTFE로 코팅된 스텐트가 재협착률을 낮추고 혈관 내 치료 후 임상 결과를 개선할 수 있는 가능성을 강조하며, 코팅된 스텐트와 비코팅된 풍선 확장형 스텐트의 차이점을 밝혀냈습니다. 장골동맥 전체 폐색에 대한 풍선 혈관성형술에 비해 1차 스텐트 삽입술의 이점을 더욱 뒷받침하는 것은 STAG 시험의 결과로, 스텐트 삽입술이 기술적 성공률이 높고 심각한 시술 문제 발생률이 낮다는 것을 보여주었습니다.
예를 들어, 2022년 5월에는 iVascular가 감독하는 iliCo 임상시험이 iCover의 안전성 및 유효성을 평가하기 위해 iVascular가 주관하여 하지 동맥경화증 환자의 대동맥-장골 동맥 경화증 치료에 대한 iCover의 안전성과 유효성을 평가하기 위해 이 약물을 사용한 첫 번째 임상시험을 시작했습니다.
장골 스텐트 시장 보고서 하이라이트
자기자극형 스텐트가 장골동맥 폐색증에 자주 사용된다는 사실이 여러 연구에서 입증되면서 자생적 확장형 스텐트가 시장을 휩쓸고 있습니다.
풍선 확장형 스텐트는 요골 외측에 강한 힘을 가할 수 있고 스텐트를 정확하게 삽입할 수 있기 때문에 가장 빠른 속도로 성장할 것으로 예상됩니다.
완전 폐쇄성 병변 부문은 PAD의 발병률 증가, 의학의 발전, 심혈관 질환으로 인해 가장 빠른 속도로 성장할 것으로 예상됩니다.
북미는 PAD 발생률 증가, 노인 인구 증가, 당뇨병 및 비만과 같은 위험 요소 증가로 인해 장골 스텐트 시장을 독식하고 있습니다.
주요 시장 기업은 Abbott, BD, Biotronik SE &Co KG, Boston Scientific Corporation, Cook, Getinge AB, iVascular, Medtronic, Terumo Corporation 등입니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 장골 스텐트 시장 인사이트
- 최종 용도 현황
- 장골 스텐트 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTEL 분석
- 장골 스텐트 시장 최종 용도 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 장골 스텐트 시장 : 유형별
- 주요 조사 결과
- 서론
- 자기 확장형 스텐트
- 풍선 확장형 스텐트
- 기타
제6장 세계의 장골 스텐트 시장 : 동맥 병변별
- 주요 조사 결과
- 서론
- 총장골 동맥 병변
- 중증 석회화 병변
- 완전 폐쇄성 병변
제7장 세계의 장골 스텐트 시장 : 최종 용도별
- 주요 조사 결과
- 서론
- 병원
- 외래수술센터(ASC)
- 기타
제8장 세계의 장골 스텐트 시장 : 지역
- 주요 조사 결과
- 서론
- 장골 스텐트 시장 평가 : 지역별, 2019-2032년
- 북미
- 북미 : 유형별, 2019-2032년
- 북미 : 최종 용도별, 2019년-2032년
- 북미 : 동맥 병변별, 2019년-2032년
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별, 2019-2032
- 유럽 : 최종 용도별, 2019-2032년
- 유럽 : 동맥 병변별, 2019-2032년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 아시아태평양
- 아시아태평양 : 유형별, 2019-2032
- 아시아태평양 : 최종 용도별, 2019년-2032년
- 아시아태평양 : 동맥 병변별, 2019-2032년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2019년-2032년
- 중동 및 아프리카 : 최종 용도별, 2019-2032년
- 중동 및 아프리카 : 동맥 병변별, 2019-2032년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 라틴아메리카
- 라틴아메리카 : 유형별, 2019-2032년
- 라틴아메리카 : 최종 용도별, 2019-2032년
- 라틴아메리카 : 동맥 병변별, 2019년-2032년
- 멕시코
- 브라질
- 아르헨티나
제9장 경쟁 구도
- 확장 및 인수 분석
- 확장
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Abbott
- BD
- Biotronik SE & Co KG
- Boston Scientific Corporation
- Cook
- Getinge AB
- iVascular
- Medtronic
- Terumo Corporation
- W. L. Gore & Associates, Inc
The global Iliac stent market size is expected to reach USD 1,708.54 Million by 2032, according to a new study by Polaris Market Research. The report "Iliac Stent Market Share, Size, Trends, Industry Analysis Report, By Type (Self-expandable Stents, Balloon-expandable Stents, Others); By Artery lesions; By End-use, By Region, And Segment Forecasts, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Several stents are used during iliac stent surgeries for the treatment of iliac arterial lesions and aneurysms. According to studies, stents such as the EPIC stent have shown superior clinical outcomes than others when it comes to managing iliac arterial lesions. The self-expanding EPIC stent is a promising alternative for iliac artery procedures due to its flexibility, improved healing, and decreased neointimal hyperplasia.
As per the data published by the American Heart Association (AHA), around 8.5 Mn adults in the U.S. are suffering from Peripheral Arterial Disease (PAD). PAD blocks iliac arteries; therefore, iliac stenting is required for smoother heart functioning.
In addition, iliac artery aneurysms are treated using percutaneous stent-graft implantation, which offers a replacement for open surgery graft insertion. Stent grafts are implanted during this minimally invasive treatment to treat iliac aneurysms, providing a less invasive method than conventional surgical reconstruction.
In the common iliac artery, the DISCOVER research has clarified the differences among covered and uncovered balloon-expandable stents, highlighting the potential of PTFE-covered stents to lower restenosis rates and enhance clinical outcomes following endovascular therapy. Further supporting the benefits of primary stent implantation above balloon angioplasty for full iliac artery occlusions are the results of the STAG study, which show that stent intervention is associated with a higher rate of technical success and a lower rate of significant procedural problems.
For instance, in May 2022, to assess the safety & effectiveness of iCover for treating aorto-iliac athero-sclerotic lesions in patients with the arteriopathy in the lower limbs, the iliCo study, supervised by iVascular, started its first trial with the drug.
Iliac Stent Market Report Highlights
Self-expandable stents segment dominated the market owing to various studies demonstrated self-expanding stents are commonly used for iliac artery occlusions.
Balloon-expandable stents segment expected to grow at the fastest rate, due to its capabilities such as severe radial outward force, and ability to accurately place stents.
Complete obstructive lesion segment expected to grow at the fastest rate due to rising the incidence of PAD, advancements in medicine, and cardiovascular diseases.
North America dominated the iliac stents market due to the rising incidence of PAD and rising older population and increasing risk factors such as diabetic and obesity
The key market players include Abbott, BD, Biotronik SE & Co KG, Boston Scientific Corporation, Cook, Getinge AB, iVascular, Medtronic, and Terumo Corporation.
Polaris Market Research has segmented the Iliac Stent market report based on type, artery lesions, end use, and region:
Iliac Stent, Type Outlook (Revenue - USD Million, 2019 - 2032)
- Self-expandable Stents
- Balloon-expandable Stents
- Others
Iliac Stent, Artery Lesions Outlook (Revenue - USD Million, 2019 - 2032)
- Common Iliac Artery Lesions
- Severe Calcified Lesions
- Complete Obstructive Lesions
Iliac Stent, End Use Outlook (Revenue - USD Million, 2019 - 2032)
- Hospitals
- Ambulatory surgical centers
- Others
Iliac Stent, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Iliac Stent Market Insights
- 4.1. Iliac Stent Market - End-Use Snapshot
- 4.2. Iliac Stent Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Technological advancements in iliac stent designs
- 4.2.1.2. Increasing prevalence of peripheral artery disease (PAD)
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Limited awareness and underdiagnosis
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Iliac Stent Market End-Use Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Iliac Stent Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 5.3. Self-expandable Stents
- 5.3.1. Global Iliac Stent Market, by Self-expandable Stents, by Region, 2019-2032 (USD Million)
- 5.4. Balloon-expandable Stents
- 5.4.1. Global Iliac Stent Market, by Balloon-expandable Stents, by Region, 2019-2032 (USD Million)
- 5.5. Others
- 5.5.1. Global Iliac Stent Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Iliac Stent Market, by Artery Lesions
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 6.3. Common Iliac Artery Lesions
- 6.3.1. Global Iliac Stent Market, by Common Iliac Artery Lesions, by Region, 2019-2032 (USD Million)
- 6.4. Severe Calcified Lesions
- 6.4.1. Global Iliac Stent Market, by Severe Calcified Lesions, by Region, 2019-2032 (USD Million)
- 6.5. Complete Obstructive Lesions
- 6.5.1. Global Iliac Stent Market, by Complete Obstructive Lesions, by Region, 2019-2032 (USD Million)
7. Global Iliac Stent Market, by End-Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 7.3. Hospitals
- 7.3.1. Global Iliac Stent Market, by Hospitals, By Region, 2019-2032 (USD Million)
- 7.4. Ambulatory surgical centers
- 7.4.1. Global Iliac Stent Market, by Ambulatory surgical centers, By Region, 2019-2032 (USD Million)
- 7.5. Others
- 7.5.1. Global Iliac Stent Market, by Others, By Region, 2019-2032 (USD Million)
8. Global Iliac Stent Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Iliac Stent Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Iliac Stent Market - North America
- 8.3.1. North America: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.3.2. North America: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.3.3. North America: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.3.4. Iliac Stent Market - U.S.
- 8.3.4.1. U.S.: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.3.5. Iliac Stent Market - Canada
- 8.3.5.1. Canada: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4. Iliac Stent Market - Europe
- 8.4.1. Europe: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.3. Europe: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.4. Iliac Stent Market - UK
- 8.4.4.1. UK: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.4.3. UK: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.5. Iliac Stent Market - France
- 8.4.5.1. France: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.5.3. France: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.6. Iliac Stent Market - Germany
- 8.4.6.1. Germany: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.7. Iliac Stent Market - Italy
- 8.4.7.1. Italy: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.8. Iliac Stent Market - Spain
- 8.4.8.1. Spain: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.9. Iliac Stent Market - Netherlands
- 8.4.9.1. Netherlands: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.4.10. Iliac Stent Market - Russia
- 8.4.10.1. Russia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5. Iliac Stent Market - Asia Pacific
- 8.5.1. Asia Pacific: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.4. Iliac Stent Market - China
- 8.5.4.1. China: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.4.3. China: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.5. Iliac Stent Market - India
- 8.5.5.1. India: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.5.3. India: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.6. Iliac Stent Market - Malaysia
- 8.5.6.1. Malaysia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.7. Iliac Stent Market - Japan
- 8.5.7.1. Japan: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.8. Iliac Stent Market - Indonesia
- 8.5.8.1. Indonesia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.5.9. Iliac Stent Market - South Korea
- 8.5.9.1. South Korea: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.6. Iliac Stent Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.6.4. Iliac Stent Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.6.5. Iliac Stent Market - UAE
- 8.6.5.1. UAE: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.6.6. Iliac Stent Market - Israel
- 8.6.6.1. Israel: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.6.7. Iliac Stent Market - South Africa
- 8.6.7.1. South Africa: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.7. Iliac Stent Market - Latin America
- 8.7.1. Latin America: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.7.3. Latin America: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.7.4. Iliac Stent Market - Mexico
- 8.7.4.1. Mexico: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.7.5. Iliac Stent Market - Brazil
- 8.7.5.1. Brazil: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
- 8.7.6. Iliac Stent Market - Argentina
- 8.7.6.1. Argentina: Iliac Stent Market, by Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Iliac Stent Market, by End-Use, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Iliac Stent Market, by Artery Lesions, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. BD
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Biotronik SE & Co KG
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Boston Scientific Corporation
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Cook
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Getinge AB
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. iVascular
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Medtronic
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Terumo Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. W. L. Gore & Associates, Inc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
